# Study to Determine Efficacy and Safety of Inhaled AeroLEF in the Treatment of Acute Post-op Pain in Adult Patients Undergoing Elective Orthopedic Surgery

> **NCT00286065** · PHASE2 · COMPLETED · sponsor: **YM BioSciences** · enrollment: 123 (—)

## Conditions studied

- Pain

## Interventions

- **DRUG:** AeroLEF

## Key facts

- **NCT ID:** NCT00286065
- **Lead sponsor:** YM BioSciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 123 (—)
- **Last updated:** 2007-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00286065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00286065, "Study to Determine Efficacy and Safety of Inhaled AeroLEF in the Treatment of Acute Post-op Pain in Adult Patients Undergoing Elective Orthopedic Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00286065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*